Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling effect on clients.

Global biopharmaceutical manufacturing firm Rentschler Biopharma will shutter its United Kingdom facility as the ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.sbqKNnJW.js ...

The company considers its proprietary technology platforms as the cornerstone of its business model. WuXi has a wide range of technical platforms for state-of-the-art biologics innovations ...

AbCellera Biologics Inc (ABCL) stock saw a decline, ending the day at $3.2 which represents a decrease of $-0.10 or -3.03% from the prior close of $3.3. The stock opened at $3.33 and touched a low of ...

Having undertaken over 300 surveys for vaious clients throught Australia, Biologic's ecologists in conjunction with Onshore Environmental have extensive experience in the managing and conducting of ...